Goyal Aluminiums Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Goyal Aluminiums Ltd is ₹ 6.4 as of 14 Aug 11:29 . The P/E Ratio of Goyal Aluminiums Ltd changed from 121.3 on March 2022 to 51.3 on March 2025 . This represents a CAGR of -19.36% over 4 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Goyal Aluminiums Ltd changed from ₹ 129.89 crore on March 2022 to ₹ 117.04 crore on March 2025 . This represents a CAGR of -2.57% over 4 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Goyal Aluminiums Ltd for the Jun '26 is ₹ 19.52 crore as compare to the Mar '26 revenue of ₹ 28.61 crore. This represent the decline of -31.77% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Goyal Aluminiums Ltd for the Jun '26 is ₹ 0.62 crore as compare to the Mar '26 ebitda of ₹ 2.27 crore. This represent the decline of -72.69% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Goyal Aluminiums Ltd changed from ₹ 0.5 crore to ₹ 0.43 crore over 9 quarters. This represents a CAGR of -6.48% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Goyal Aluminiums Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Goyal Aluminiums Ltd

Goyal Aluminiums Limited was erstwhile incorporated with the name of 'Advitiya Trade India Limited' as a Limited Company on March 22, 2017.
Subsequently, the Company has taken over the running concern in the name and style of 'Goyal Sales' w.e.f.
April 01, 2017.
Thereafter, the Company changed its name from Advitiya Trade India Limited to Goyal Aluminiums Limited on August 21, 2021. Shri Om Prakash Aggarwal had started Goyal and Company, a proprietary concern at Delhi in 1996 and ran it till March 2010.
Goyal & Co. was a trading concern which traded mainly in Aluminium and other metals, textiles and other hardware products.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Goyal Aluminiums Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Goyal Aluminiums Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Goyal Aluminiums Ltd is 79 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Goyal Aluminiums Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Goyal Aluminiums Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Goyal Aluminiums Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Goyal Aluminiums Ltd stock price is INR ₹5.59. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Goyal Aluminiums Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Goyal Aluminiums Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.